Heart Disease Trial, Recruiting NCT05272618 Sponsor: Chonnam National University Hospital Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT05272618
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 19 years or older who have had a heart attack, confirmed by specific blood test results (called cardiac troponin) combined with symptoms of reduced blood flow to the heart
  • People whose heart arteries are found to be not significantly blocked — meaning less than 50% narrowing, or a pressure-based test (called FFR) showing good blood flow
  • People with no previous history of coronary artery disease (heart artery problems)
  • People who had an invasive heart artery imaging procedure (called coronary angiography) within 24 hours of arriving at the hospital
  • People for whom doctors consider both invasive and non-invasive heart artery assessment tests to be appropriate

Who may not be able to join:

  • People whose heart arteries show significant blockages
  • People whose symptoms are found to be caused by another condition, such as a serious infection (sepsis), a blood clot in the lungs (pulmonary embolism), heart muscle inflammation (myocarditis), stress-related heart condition (Takotsubo syndrome), a spontaneous tear in a heart artery, or other heart muscle diseases
  • People who are in cardiogenic shock (when the heart cannot pump enough blood) or who have had a cardiac arrest
  • People with serious non-heart-related health conditions where life expectancy is less than one year
  • People who are pregnant or currently breastfeeding
  • People who are unable to give their own consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Young Joon Hong, MD, PhD, Chonnam National University Medical School; Chonnam National University Hospital

Phone: 82-10-2055-7919

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chonnam National University Hospital
Registry
ClinicalTrials.gov
Start date
14 February 2022
Est. completion
31 December 2029

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

MACCE

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov